SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-193726
Filing Date
2022-07-14
Accepted
2022-07-14 16:03:35
Documents
15
Period of Report
2022-07-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d326023d8k.htm   iXBRL 8-K 32052
2 EX-1.1 d326023dex11.htm EX-1.1 181759
3 EX-5.1 d326023dex51.htm EX-5.1 9576
7 GRAPHIC g326023dsp49.jpg GRAPHIC 2488
  Complete submission text file 0001193125-22-193726.txt   399120

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA plrx-20220711.xsd EX-101.SCH 2860
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE plrx-20220711_lab.xml EX-101.LAB 17236
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plrx-20220711_pre.xml EX-101.PRE 10815
9 EXTRACTED XBRL INSTANCE DOCUMENT d326023d8k_htm.xml XML 3245
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Filer) CIK: 0001746473 (see all company filings)

IRS No.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39303 | Film No.: 221083065
SIC: 2834 Pharmaceutical Preparations